Mesoblast Ltd - ADR operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mesoblast Ltd - ADR with three other
companies in this sector in the United States:
Nascent Biotech Inc
sales of $3.00 million
Kalvista Pharmaceuticals Inc
Aytu Bioscience Inc
Sales fell dramatically in 2017:
During the year ended June of 2017, sales at
Mesoblast Ltd - ADR were $2.41 million.
decrease of 94.3%
versus 2016, when the company's sales were $42.55 million.